Terms: = Thyroid cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Treatment
14 results:
1. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating jak2/STAT3 signaling.
Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
[TBL] [Abstract] [Full Text] [Related]
2. Effects of Ruxolitinib and Calcitriol Combination treatment on Various Molecular Subtypes of Breast cancer.
Schneider J; Jeon YW; Suh YJ; Lim ST
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269680
[TBL] [Abstract] [Full Text] [Related]
3. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
[TBL] [Abstract] [Full Text] [Related]
4. A Case of Thrombotic Vasculopathy in the Setting of High-Dose Hydroxyurea Use.
Michalak J; Simman R; Oostra D
Wounds; 2021 Dec; 33(12):E79-E84. PubMed ID: 34882096
[TBL] [Abstract] [Full Text] [Related]
5. Curcumin inhibits proliferation and invasion of papillary thyroid carcinoma cells by inhibiting the jak2 / STAT3 pathway.
Hu Y; Zhou N; Zhu Q
J BUON; 2021; 26(4):1635-1641. PubMed ID: 34565029
[TBL] [Abstract] [Full Text] [Related]
6. PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced thyroid cancer.
Gray KD; McCloskey JE; Vedvyas Y; Kalloo OR; Eshaky SE; Yang Y; Shevlin E; Zaman M; Ullmann TM; Liang H; Stefanova D; Christos PJ; Scognamiglio T; Tassler AB; Zarnegar R; Fahey TJ; Jin MM; Min IM
Clin Cancer Res; 2020 Nov; 26(22):6003-6016. PubMed ID: 32887724
[TBL] [Abstract] [Full Text] [Related]
7. S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of jak2/STAT3 pathways.
Liu Y; Bi T; Yuan F; Gao X; Jia G; Tian Z
Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2507-2515. PubMed ID: 32219484
[TBL] [Abstract] [Full Text] [Related]
8. Knockdown of LINC00511 promotes radiosensitivity of thyroid carcinoma cells via suppressing jak2/STAT3 signaling pathway.
Chen Y; Bao C; Zhang X; Lin X; Fu Y
Cancer Biol Ther; 2019; 20(9):1249-1257. PubMed ID: 31135274
[TBL] [Abstract] [Full Text] [Related]
9. Salidroside inhibits migration and invasion of poorly differentiated thyroid cancer cells.
Shang H; Wang S; Yao J; Guo C; Dong J; Liao L
Thorac Cancer; 2019 Jun; 10(6):1469-1478. PubMed ID: 31120636
[TBL] [Abstract] [Full Text] [Related]
10. Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models.
Pinto N; Prokopec SD; Vizeacoumar F; Searle K; Lowerison M; Ruicci KM; Yoo J; Fung K; MacNeil D; Lacefield JC; Leong HS; Mymryk JS; Barrett JW; Datti A; Boutros PC; Nichols AC
PLoS One; 2018; 13(11):e0207152. PubMed ID: 30419054
[TBL] [Abstract] [Full Text] [Related]
11. Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.
Lim ST; Jeon YW; Gwak H; Kim SY; Suh YJ
Mol Med Rep; 2018 Apr; 17(4):5581-5588. PubMed ID: 29436642
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of autophagy enhances synergistic effects of Salidroside and anti-tumor agents against colorectal cancer.
Li H; Chen C
BMC Complement Altern Med; 2017 Dec; 17(1):538. PubMed ID: 29246220
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-204 targets jak2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
[TBL] [Abstract] [Full Text] [Related]
14. Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the jak2-Stat3-Mcl1 axis.
Abdulghani J; Allen JE; Dicker DT; Liu YY; Goldenberg D; Smith CD; Humphreys R; El-Deiry WS
PLoS One; 2013; 8(9):e75414. PubMed ID: 24086526
[TBL] [Abstract] [Full Text] [Related]
